Moelis & Company Announces Key Senior Leadership Changes
Navid Mahmoodzadegan Appointed Chief Executive Officer
Jeff Raich Appointed Executive Vice Chairman
NEW YORK, June 09, 2025--(BUSINESS WIRE)--Moelis & Company (NYSE: MC), a leading global independent investment bank, today announced key senior leadership changes, which are the result of the Firm's long-term leadership transition planning and will be effective as of October 1, 2025. Founder Ken Moelis, who has served as Chief Executive Officer since the Firm's inception in 2007, will assume the role of Executive Chairman and will continue to focus on advising clients on their most critical strategic decisions. Navid Mahmoodzadegan, Co-Founder and Co-President, will succeed Ken as Chief Executive Officer and will also join the Board of Directors. Jeff Raich, Co-Founder and Co-President, will become Executive Vice Chairman of Moelis and will continue to lead key business areas of the Firm.
Ken said, "I have never felt better about our Firm and the opportunities ahead. We have the highest quality talent and the most extensive capabilities for clients in our history. This is the right moment to elevate the next generation of leadership and create further opportunities for internal growth. Navid is a founder of our Firm and has been a trusted partner to me for 30 years. As Co-President, he has been involved in every major decision we have made and has been a key driver of our Firm's most impactful strategic growth initiatives. He's a unique talent and one of the best strategic advisors I have ever worked with. Navid has the full support of our Board to lead Moelis into the future, building on our strong foundation to drive sustained growth and invest in the next generation of talent. Navid, Jeff and I share a long-term vision and deep commitment to fostering a collaborative and entrepreneurial environment that prioritizes exceptional client service and innovation."
Navid commented, "I am incredibly proud of what we have achieved together these past 18 years since founding Moelis and am honored and excited to have the opportunity to serve as CEO at this important moment in the evolution of our Firm. As we move forward, we will continue to put clients first – that has always been the key to the Firm's long-term success and achieving outstanding results for our shareholders. We have never been better positioned to capitalize on the significant growth opportunities ahead."
Jeff added, "Moelis has always been defined by entrepreneurial thinking, deep client relationships, and a culture focused on our people. Ken, Navid and I have achieved so much together in our 30 years of partnership, and it feels like we are just getting started. I look forward to continuing to bring creative solutions to our clients and executing on our growth plans together with my colleagues across our organization."
Ken concluded, "Jeff's experience and judgment have shaped Moelis at every stage since our founding, and his leadership will be critical to our next chapter. I look forward to serving our clients and helping drive the Firm's continued success alongside Navid, Jeff and our leadership team for years to come."
About Navid Mahmoodzadegan
Navid Mahmoodzadegan is a Co-Founder and Co-President of Moelis & Company, where he has co-led the Firm's investment banking business and driven strategic growth since its founding. An accomplished banker and advisor with 30 years of experience, Navid previously served as Global Head of Media Investment Banking at UBS. Prior to this, he was an investment banker at Donaldson, Lufkin & Jenrette and practiced law as an attorney at Irell & Manella.
Navid holds an A.B. with Highest Distinction from the University of Michigan (Phi Beta Kappa) and a J.D. from Harvard Law School, magna cum laude. He currently serves on the Taft School Board of Trustees and on the President's Advisory Group at the University of Michigan. He previously served on the National Board of Directors of JumpStart and as Board Chair for the Carlthorp School Board of Trustees.
About Moelis & Company
Moelis & Company ("Moelis") is a leading global independent investment bank that provides innovative strategic advice and solutions to a diverse client base, including corporations, governments and financial sponsors. The Firm assists its clients in achieving their strategic goals by offering comprehensive integrated financial advisory services across all major industry sectors. Moelis & Company's experienced professionals advise clients on their most critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. The Firm serves clients from locations across North and South America, Europe, the Middle East, and Asia-Pacific. For further information, please visit: www.moelis.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250609606398/en/
Contacts
Media Contact: Melissa ChilesMoelis & CompanyT: + 1 212 883 3583press@moelis.com
Investor Contact: Matt TsukroffMoelis & CompanyT: + 1 212 883 3800M: +1 917 526 2340matthew.tsukroff@moelis.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Oversold Abbott Laboratories (ABT) Could Offer a Healthy Dividend Opportunity
Abbott Laboratories (NYSE:ABT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. The company reported strong earnings in the second quarter of 2025. It posted revenue of $11.1 billion, which showed a 7.37% growth on a YoY basis. The company reported GAAP diluted earnings per share of $1.01, while adjusted diluted EPS came in at $1.26. Gross margin was 52.7% of sales on a reported basis, with the adjusted gross margin reaching 57.0%, representing a 100 basis point improvement. Abbott Laboratories (NYSE:ABT) reiterated its guidance and pointed to strong momentum in both its devices and nutrition segments as it moves into the second half of the year. A brief valuation analysis, based on a five-year free cash flow CAGR of 5.74%— calculated using 6% growth in operating cash flow and 2% growth in capital expenditures— suggests that the current share price of $120.51 offers promising return potential. On June 13, Abbott Laboratories (NYSE:ABT) declared a quarterly dividend of $0.59 per share, which was in line with its previous dividend. This was the company's 406th consecutive quarterly dividend. In addition, ABT has raised its payouts for 53 years in a row. The stock offers a quarterly dividend of 1.86%, as of July 25. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
12 minutes ago
- Yahoo
Why Oversold Lockheed Martin (LMT) Could Be a Defensive Dividend Powerhouse
Lockheed Martin Corporation (NYSE:LMT) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. Two fighter jets in flight, highlighting the technology and experience of the companies combat aircraft. The company has long held a leading position in the US aerospace and defense sector. It supplies advanced technologies and services to the US Department of Defense, NASA, and various international government agencies. Its space division is one of the company's four key segments. For investors looking for a diversified and established aerospace company with ties to the growing space industry, Lockheed Martin may be a strong addition to their portfolio. Lockheed Martin Corporation (NYSE:LMT) maintained a strong cash position, reinforcing its appeal as a reliable dividend investment. In the most recent quarter, the company reported an operating cash flow of $201 million. It also returned $1.3 billion to investors through dividends and share repurchases. On June 26, Lockheed Martin Corporation (NYSE:LMT) declared a quarterly dividend of $3.30 per share, which was consistent with its previous dividend. The company has been rewarding shareholders with growing dividends for the past 22 years. The stock offers a dividend yield of 3.11%, as of July 25. While we acknowledge the potential of LMT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
12 minutes ago
- Yahoo
Oversold but Not Overlooked: Why FactSet (FDS) Deserves a Second Look
FactSet Research Systems Inc. (NYSE:FDS) is included among the 10 Oversold Dividend Stocks to Buy According to Hedge Funds. An investment banker consulting with a customer on their portfolio in a professional setting. The company's third-quarter earnings demonstrated the successful implementation of its enterprise solution strategy. With a strong pipeline and growing momentum, it appeared well-positioned to close the fiscal year on a solid note. FactSet Research Systems Inc. (NYSE:FDS) reported revenue of $585.5 million in fiscal Q3 2025, up 6% from the same period last year. The revenue also beat analysts' estimates by $4.62 million. As of May 31, 2025, the company's Annual Subscription Value (ASV) reached $2.33 billion, an increase from $2.2 billion recorded on the same date in 2024. On an organic basis, ASV stood at $2.3 billion, reflecting a year-over-year growth of 4.5%, or $98.5 million. FactSet Research Systems Inc. (NYSE:FDS)'s cash position also remained strong. The company reported an operating cash flow of $253.8 million and its free cash flow was $228.6 million, both up by 6.5% and 5.4%, respectively. In addition, it returned $41.6 million to shareholders through dividends, which showed the commitment toward its investors. FactSet Research Systems Inc. (NYSE:FDS) currently offers a quarterly dividend of $1.10 per share, having raised it by 6% in May 2025. This was the company's 26th consecutive year of dividend growth. The stock has a dividend yield of 1.05%, as of July 25. While we acknowledge the potential of FDS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
